Gene: NKAPD1
Official Full Name: NKAP domain containing 1provided by HGNC
Gene Summary: Enables identical protein binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15722 | NKAPD1 Knockout cell line (HeLa) | Human | NKAPD1 | 1:3~1:6 | Negative | Online Inquiry |
KO15723 | NKAPD1 Knockout cell line (HCT 116) | Human | NKAPD1 | 1:2~1:4 | Negative | Online Inquiry |
KO15724 | NKAPD1 Knockout cell line (HEK293) | Human | NKAPD1 | 1:3~1:6 | Negative | Online Inquiry |
KO15725 | NKAPD1 Knockout cell line (A549) | Human | NKAPD1 | 1:3~1:4 | Negative | Online Inquiry |
NKAPD1 Gene Knockout Cell Lines represent a cutting-edge tool for researchers aiming to study the role of the NKAPD1 gene in various biological processes. These cell lines are genetically engineered to have a complete knockout of the NKAPD1 gene, allowing scientists to explore the functional consequences of its absence. NKAPD1, known for its role in T cell signaling and potential implications in autoimmune diseases, has been a focal point of research for understanding cellular pathways related to immune responses.
The key mechanism of these knockout cell lines resides in the precise gene-editing technology utilized to disable NKAPD1 expression. By employing CRISPR-Cas9 technology, these cells exhibit a loss of NKAPD1 protein production, enabling researchers to investigate downstream signaling pathways, cellular metabolism, and gene regulation without interference from NKAPD1. This precise knockout provides an invaluable model for elucidating the gene's contribution to pathophysiological conditions, particularly in immunology and oncology.
The scientific significance of NKAPD1 Gene Knockout Cell Lines extends to their diverse applications in both basic and translational research settings. They serve as powerful models for understanding T cell dysregulation in diseases like multiple sclerosis and lupus, facilitating the development of targeted therapies. Additionally, these cell lines can contribute to drug discovery efforts by providing insights into how NKAPD1 affects cellular responses to therapeutic agents.
What sets NKAPD1 Gene Knockout Cell Lines apart from alternatives is the rigor of their generation and validation. Each line is comprehensively characterized to ensure consistent performance and reproducibility, crucial for high-stakes research. Moreover, their availability in various cell types adds versatility, catering to the specific needs of researchers across different disciplines.
In summary, NKAPD1 Gene Knockout Cell Lines are an essential asset for scientists committed to advancing our understanding of immune system dynamics and related disorders. Backed by our company's extensive expertise in genetic engineering and commitment to quality, we provide outstanding products that empower researchers and clinicians alike to make meaningful discoveries in biotechnology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.